Friday, October 5, 2018: 7:15 AM-8:15 AM
Room: S 152-154
At the conclusion of this session, participants will be able to:
- review the data on the use of fecal microbiota transplants in patients with infectious diseases.
- discuss the development of novel therapies designed to modify the microbiome to improve human health.
Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists
Pediatric ID, Trainee, Adult ID
Vincent B. Young, MD, PhD, FIDSA, University of Michigan
Maximum of 1.00 hours of AMA PRA Category 1 Credit™
ACPE 1 knowledge-based contact hours of pharmacy CE
V. B. Young,
No financial benefit